G Spencer-Green

The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

Ferdinand C. Breedveld, Michael H. Weisman, Arthur F. Kavanaugh et al. · Arthritis & Rheumatism · 2005 · 1.8K citations

Medicine, Pharmacology, Pharmacotherapy +17

Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes

Mark C. Genovese, Joan M. Bathon, Richard W. Martin et al. · Arthritis & Rheumatism · 2002 · 733 citations

Medicine, Clinical Sciences, Pharmacotherapy +13

Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.

Roy A. Fava, Nancy J. Olsen, G Spencer-Green et al. · The Journal of Experimental Medicine · 1994 · 526 citations · Full text

Medicine, Immunology, Pathobiology +17

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation

John P. Clancy, Steven M. Rowe, Frank J. Accurso et al. · Thorax · 2011 · 496 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

A multicenter study of outcome in systemic lupus erythematosus.

Ellen M. Ginzler, Herbert S. Diamond, Max Weiner et al. · Arthritis & Rheumatism · 1982 · 390 citations

Medicine, Clinical Sciences, Internal Medicine +17